Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2012-08-16 Interim / Quarterly Rep…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half (1H) of 2012, detailing sales, EBIT, net profit, and industry-specific performance. It contains substantive financial data, tables, and management analysis of the results. It is not a short announcement or a certification, but rather the actual interim financial report for the period, fitting the definition of an Interim / Quarterly Report (IR). H1 2012
2012-08-16 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text, which is very short (398 characters), announces that Novozymes initiated a share buyback program ('aktietilbagekøbsprogram') under a specific EU regulation (No. 2273/2003) for up to 1,000 million DKK between January 20, 2012, and December 31, 2012. This directly relates to the company buying back its own shares. The classification 'Transaction in Own Shares' (POS) is the most appropriate fit. The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this might be a brief announcement, but the core content is a definitive transaction notice, making POS stronger than RPA/RNS, as it describes the action itself rather than just announcing the publication of a report.
2012-08-10 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a previously initiated 'share buyback program' (e.g., 'Novozymes initiated a share buyback program'). It provides a table showing the number of shares bought back, the average purchase price, and the transaction value over several days in August 2012. This content directly relates to the company repurchasing its own stock. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document length is short (2795 chars), but it contains the full details of the transactions, making it the report itself, not just an announcement of a report.
2012-08-10 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes initiated a 'share buyback program' and details the amount and period for buying back 'B shares'. This directly relates to the company repurchasing its own stock. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although the text ends with 'Read the full announcement in PDF format,' suggesting it might be an RPA, the core content is a direct announcement of the buyback program itself, making POS the most accurate classification for the subject matter, especially given the short length which implies this is the primary announcement.
2012-08-03 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text, which is very short (398 characters), announces that Novozymes initiated a share buyback program ('aktietilbagekøbsprogram') under a specific EU regulation (No. 2273/2003) for up to 1,000 million DKK between January 20, 2012, and December 31, 2012. This directly relates to the company buying back its own shares. The classification 'Transaction in Own Shares' (POS) is the most appropriate fit. The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this might be a brief announcement, but the core content is a definitive transaction notice, making POS stronger than RPA/RNS, as it describes the action itself rather than just announcing the publication of a report.
2012-08-03 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes initiated a 'share buyback program' and details the amount and period for buying back 'B shares'. This directly relates to the company repurchasing its own stock. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although the text ends with 'Read the full announcement in PDF format,' suggesting it might be an RPA, the core content is a direct announcement of the buyback program itself, making POS the most accurate classification for the subject matter, especially given the short length which implies this is the primary announcement.
2012-07-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.